A synthetic analogue of phosphatidylinositol mannoside is an efficient adjuvant

References

• Rastogi, N., David H.L. Mechanisms of pathogenicity in mycobacteria. Biochimie. 1988,70(8),1101–1120.
   PubMedGoogle Scholar
• Cox, J, Coulter, A. Prospects for the development of new vaccine adjuvants. BioDrugs. 1999,12(6),439–453.
   PubMedGoogle Scholar
• Briken, V, Porcelli, S.A., Besra, G.S., Kremer, L. Mycobacterial lipoarabinomannan and related lipoglycans: From biogenesis to modulation of the immune response. Mol Microbiol. 2004,53(2),391–403.
   PubMedGoogle Scholar
• Azuma, I, Seya, T. Development of immunoadjuvants for immunotherapy of cancer. Int. Immunopharmacol. 2001,1(1),1249–1259.
   PubMedGoogle Scholar
• Pichichero, M.E. Improving vaccine delivery using novel adjuvant systems. Hum VaccineS. 2008,4(4),262–270.
   PubMedGoogle Scholar
• Chedid, L, Audibert, F. Chemically defined bacterial products with immunopotentiating activity. J Infect Dis. 1977,136,S246–251.
   Google Scholar
• Petrovsky, N. Freeing vaccine adjuvants from dangerous immunological dogma. Expert Rev Vaccines. 2008,7 (1),7–10.
   PubMedGoogle Scholar
• Khoo, K.H., Dell A., Morris, H.R., et al. Structural definition of acylated phosphatidylinositol mannosides from Mycobacterium tuberculosis: Definition of a common anchor for lipomannan and lipoarabinomannan. Glycobiology. 1995,5(2),117–127.
   PubMedGoogle Scholar
• Gilleron, M., Ronet, C., Mempel, M., et al. Acylation state of the phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette Guérin and ability to induce granuloma and recruit natural killer T cells. J Biol Chem. 2001,276(37),34896–904.
   PubMedGoogle Scholar
• Gilleron, M, Quesniaux, V.F., Puzo, G. Acylation state of the phosphatidylinositol hexamannosides from Mycobacterium bovis bacillus Calmette Guerin and mycobacterium tuberculosis H37Rv and its implication in Toll-like receptor response. J Biol Chem. 2003,278(32),29880–29889.
   PubMedGoogle Scholar
• Ainge, G.D., Parlane N.A., Denis, M, et al. Phosphatidylinositol mannoside ether analogues: Syntheses and interleukin-12- inducing properties. J Org Chem. 2007,7(14),5291–5296.
   Google Scholar
• Parlane, N.A., Denis, M, Severn, W.B., et al. Phosphatidylinositol mannosides are efficient mucosal adjuvants. Immunol Invest. 2008,37(2),129–142.
   PubMedGoogle Scholar
• Ainge, G. D., Parlane, N. A., Denis, M., et al. Phosphatidylinositol mannosides: Synthesis and adjuvant properties of phosphatidylinositol di- and tetramannosides. Bioorg Med Chem. 2006,14(22),7615–7624.
   PubMedGoogle Scholar
• Fitzmaurice, K, Klenerman, P. Cellular immunity and acute hepatitis C infection. Curr. Pharm. Des. 2008,14(17),1666–1677.
   PubMedGoogle Scholar
• Strickland, G.T., El-Kamary, S.S., Klenerman, P., Nicosia, A. Hepatitis C vaccine: Supply and demand. Lancet Infect Dis. 2008,8 (6),379–386.
   PubMedGoogle Scholar
• Wedlock, D.N., Denis, M, Painter, G.F., et al. Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone. Clin Vaccine Immunol. 2008,15 (5),765–772.
   PubMedGoogle Scholar
• Sprott, G.D., Dicaire, C.J., Gurnani, K., et al. Activation of dendritic cells by liposomes prepared from phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette-Guerin and adjuvant activity in vivo. Infect Immun. 2004,72(9),5235–5246.
   PubMedGoogle Scholar
• Mehta, P.K., Khuller, G.K. Protective immunity to experimental tuberculosis by mannophosphoinositides of mycobacteria. Med. Microbiol. Immunol. 1988,177(21),265–284.
   PubMedGoogle Scholar
• Sayers, I, Severn, W., Scanga, C.B., et al. Suppression of allergic airway disease using mycobacterial lipoglycans. J Allergy Clin Immunol. 2004,114(2),302–309.
   PubMedGoogle Scholar
• Fischer, K, Scotet, E, Niemeyer, M, et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc Natl Acad Sci USA. 2004,101(29),10685–10690.
   PubMedGoogle Scholar
• Jones, B.W., Heldwein, K.A., Means, T.K., et al. Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages. Ann Rheum Dis. 2001,60Suppl 3,iii6–12.
   PubMedGoogle Scholar
• Jones, B.W., Means, T.K., Heldwein, K.A., et al. Different Toll-like receptor agonists induce distinct macrophage responses. J Leukoc Biol. 2001,69(6),1036–1044.
   PubMedGoogle Scholar
• Rojas, R.E., Thomas, J.J., Gehring, A.J., et al. Phosphatidylinositol mannoside from Mycobacterium tuberculosis binds alpha5beta1 integrin (VLA-5) on CD4+ T cells and induces adhesion to fibronectin. J Immunol. 2006,177(5),2959–2968.
   PubMedGoogle Scholar
• Torrelles, J.B., Azad, A.K., Schlesinger, L.S. Fine discrimination in the recognition of individual species of phosphatidyl-myo-inositol mannosides from Mycobacterium tuberculosis by C-type lectin pattern recognition receptors. J Immunol. 2006,177(3),1805–1816.
   PubMedGoogle Scholar
• Persing, D.H., Coler, R.N., Lacy, M.J., et al. Taking toll: Lipid A mimetics as adjuvants and immunomodulators. Trends Microbiol. 2002,10(10 Suppl),S32–S37.
   Google Scholar
• Marshall, J.D., Abtahi, S., Eiden, J.J., et al. Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy. J Allergy Clin Immunol. 2001,108(2),191–197.
   PubMedGoogle Scholar
• Hegazy, D., Thurairajah, P., Metzner, M., et al. Interleukin 12B gene polymorphism and apparent resistance to hepatitis C virus infection. Clin Exp Immunol. 2008,152(3) ,538–541.
   PubMedGoogle Scholar
• Waggoner, S.N., Hall, C.H., Hahn, Y.S. HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production. J Leukoc Biol. 2007,82(6),1407–19.
   PubMedGoogle Scholar
• Pachiadakis, I, Pollara G, Chain, B.M., Naoumov, N.V. Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence? Lancet Infect Dis. 2005,5(5),296–304.
   PubMedGoogle Scholar
• Jin, B., Wang, R.Y., Qiu, Q., et al. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA. Immunology. 2007,122(1),15–27.
   PubMedGoogle Scholar